Medicine and Dentistry
Patient
100%
Therapeutic Procedure
45%
Inpatient
36%
Apoplexy
31%
Cells
29%
Association
26%
Analysis
24%
Age
22%
Assessment
21%
Diagnosis
19%
Woman
19%
Brain
19%
Systematic Review
19%
Adult
18%
Tissues
18%
Magnetic Resonance Imaging
17%
Meta-Analysis
15%
Symptom
15%
Hospital
14%
Surgery
14%
Child
13%
Health
13%
Combination Therapy
13%
Mortality
12%
Randomized Controlled Trial
12%
Death
12%
Cohort Analysis
12%
Pregnancy
12%
Follow up
11%
Serositis
10%
Evaluation Study
10%
Myocardial Infarction
10%
Brain Ischemia
10%
Acute Coronary Syndrome
10%
Biological Marker
9%
In Vitro
9%
Male
9%
Dementia
9%
Phenotype
9%
Measurement
9%
Man
9%
Cardiovascular System
8%
COVID-19
8%
Injury
8%
Enalapril Maleate
8%
Diagnostics
8%
Glucocorticoid
8%
Lesion
8%
Infection
8%
Alzheimer's Disease
7%
Survival
7%
Incidence
7%
Cardiovascular Disease
7%
Regulatory Mechanism
7%
Protein
7%
Liver
7%
Childbirth
7%
Blood
7%
White Matter
7%
Stem Cell
7%
Obesity
6%
Cognition
6%
Prevalence
6%
Endothelial Cell
6%
Experience
6%
Consensus
6%
Human
6%
Computer Assisted Tomography
6%
Mental Health
6%
Blood Pressure
6%
Female
6%
Neoplasm
6%
Receptor
6%
Hypertension
6%
Plasma
6%
Placebo
6%
Lung
6%
Differentiation
6%
Complication
5%
Clinical Trial
5%
Cerebral Hemorrhage
5%
Drug
5%
Pathology
5%
Macrophage
5%
Maturity Onset Diabetes of the Young
5%
Diabetes
5%
Predictor
5%
Odds Ratio
5%
Variant Creutzfeldt-Jakob Disease
5%
Chemotherapeutic Agent
5%
Heart
5%
Accuracy
5%
Delirium
5%
Health Care Cost
5%
Malignant Neoplasm
5%
Screening
5%
Culture
5%
Adipose Tissue
5%
Messenger RNA
5%
Morbidity
5%
Biochemistry, Genetics and Molecular Biology
Mouse
23%
Nested Gene
22%
Association
17%
Protein
16%
Development
15%
Genetics
12%
Age
11%
Glucocorticoid
11%
Electric Potential
10%
Mutation
10%
Phenotype
9%
Magnetic Resonance Imaging
8%
Regulatory Mechanism
7%
Rat
7%
Taxonomy
7%
Time
7%
Sample
6%
Gene Expression
5%
Genome-Wide Association Study
5%
Health
5%
Hydroxysteroid Dehydrogenase
5%
Prion
5%
Dynamics
5%
Messenger RNA
5%
Pregnancy
5%
Human
5%
Metabolic Pathway
5%